GSK Plc is a global pharmaceutical and life sciences company headquartered in London, United Kingdom. Established in 1999, GSK operates as a plc, signifying a publicly traded company. The company’s core business focuses on the research, development, manufacture, and marketing of prescription medicines, over-the-counter products, and consumer healthcare solutions. GSK’s strategic focus centers on key therapeutic areas including neuroscience, cardiovascular, and infectious diseases. The company invests significantly in innovation, driven by a robust research and development program encompassing both internal and collaborative efforts. GSK’s international presence is substantial, with operations spanning across North America, Europe, and Asia-Pacific. Currently, GSK is actively expanding its global footprint through the construction of new facilities in both the United States and the United Kingdom. These facilities are designed to integrate R&D and manufacturing capabilities, fostering a streamlined process and enhancing the company’s overall operational efficiency. The company is committed to attracting and retaining skilled talent, utilizing Visa programs for global business mobility. SIC codes include -70100: Activities of head offices, and the company’s operations are within the pharmaceutical, biotechnology, and healthcare industries.

GSK Plc is a global pharmaceutical and life sciences company headquartered in London, United Kingdom. Established in 1999, GSK operates as a plc, signifying a publicly traded company. The company’s core business focuses on the research, development, manufacture, and marketing of prescription medicines, over-the-counter products, and consumer healthcare solutions. GSK’s strategic focus centers on key therapeutic areas including neuroscience, cardiovascular, and infectious diseases. The company invests significantly in innovation, driven by a robust research and development program encompassing both internal and collaborative efforts. GSK’s international presence is substantial, with operations spanning across North America, Europe, and Asia-Pacific. Currently, GSK is actively expanding its global footprint through the construction of new facilities in both the United States and the United Kingdom. These facilities are designed to integrate R&D and manufacturing capabilities, fostering a streamlined process and enhancing the company’s overall operational efficiency. The company is committed to attracting and retaining skilled talent, utilizing Visa programs for global business mobility. SIC codes include -70100: Activities of head offices, and the company’s operations are within the pharmaceutical, biotechnology, and healthcare industries.